Skip to main content
. 2016 May 9;2016:7036415. doi: 10.1155/2016/7036415

Table 3.

Efficacy of treating pain on psychosis and agitation in patients presenting one or more clinically significant symptoms at baseline (NPI-NH ≥ 4).

Baseline (SD) 8 weeks (SD)
Control (n = 71) Intervention (n = 83) p a Control (n = 67) Intervention (n = 70) p a p changeb
Psychosis cluster 10.5 (4.7) 11.6 (5.9) 0.314 6.4 (5.3) 5.6 (6.1) 0.148 0.034
Delusion 5.6 (4.2) 6.9 (4.0) 0.043 3.2 (3.7) 2.9 (3.6) 0.770 0.031
Hallucination 3.2 (3.8) 3.3 (4.0) 0.813 2.1 (3.1) 2.1 (3.3) 0.987 0.925
Euphoria 1.7 (2.9) 1.4 (3.1) 0.211 1.0 (2.2) 0.5 (1.9) 0.027 0.758

Control (n = 128) Intervention (n = 137) p a Control (n = 117) Intervention (n = 113) p a p changeb
Agitation cluster 17.4 (9.7) 18.0 (9.6) 0.422 14.0 (11.0) 8.8 (8.8) <0.001 <0.001
Agitation/aggression 4.7 (4.0) 5.1 (4.2) 0.441 4.2 (4.0) 2.5 (3.3) 0.001 0.004
Disinhibition 3.9 (4.3) 3.5 (4.0) 0.618 3.3 (4.2) 1.9 (3.2) 0.008 0.211
Irritability 4.8 (3.6) 5.1 (4.1) 0.664 3.6 (3.6) 2.6 (3.2) 0.023 0.183
Abb. motor behaviour 4.0 (4.7) 4.3 (4.9) 0.639 2.9 (3.9) 1.8 (3.5) 0.008 0.007

aCalculated by analyzing the difference between the intervention group and control group at each measurement point using the Mann-Whitney U test.

bCalculated by analyzing the difference in change of NPI-NH score in the intervention group versus the control group from baseline to Week 8 using the Mann-Whitney U test.